The global buprenorphine transdermal patches market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Buprenorphine patches are used as a pain reliever and belongs to a class of medications called opiate (narcotic) analgesics. They support to relieve severe pain in people who need pain medication around the clock for a long time and that cannot be treated with other medications. The major factor driving the demand for the global buprenorphine transdermal patches market is the increasing demand and application as a pain reliever across the globe.
Moreover, these patches are marketed as a Schedule III medicine. It is used for the management of pain severe enough to require daily, around-the-clock and for long-term opioid treatment. Additionally, the market is also growing owing to the improvement in inpatient drug delivery during the forecast period. However, the growth of the market is hampered due to several side effects related to these patches.
To Request a Sample of our Report on Buprenorphine Transdermal Patches Market: https://www.omrglobal.com/request-sample/buprenorphine-transdermal-patches-market
Some major players in the market include Grunenthal, PurduePharma, Luye Pharma, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2020, Amneal Pharmaceuticals announced the approval of Abbreviated New Drug Application (ANDA) for a generic version of Butrans (buprenorphine) Transdermal System from the US Food and Drug Administration (FDA). The company received the approval for Butrans in 5 mcg/hr, 7.5 mcg/hr, 10 mcg/hr, 15 mcg/hr and 20 mcg/hr. Additionally, the company was also granted the Competitive Generic Therapy (CGT) designation and 180 days of exclusivity for the 7.5 mcg/hr dose.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Grunenthal, Luye Pharma, and Amneal Pharmaceuticals, among others.
A full Report of Buprenorphine Transdermal Patches Market is Available @ https://www.omrglobal.com/industry-reports/buprenorphine-transdermal-patches-market
Global Buprenorphine Transdermal Patches Market Report by Segment
By Type
- 5mcg/h
- 7.5mcg/h
- 10mcg/h
- 15 mcg/h
- 20 mcg/h
By Application
- Cancer Pain
- Others
Global Buprenorphine Transdermal Patches Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
